by Crestone, Inc. | Jun 27, 2022 | Events
Crestone Presents at the Colorado Mycobacteria Conference 2022: Focus on NTM Poster Presentations: In vitro Activity and Mode of Action of CRS0393, a Potent MmpL3 Inhibitor as a Novel Antimycobacterial Agent Pharmacokinetics of a Novel Antimycobacterial Agent,...
by Crestone, Inc. | Jun 27, 2022 | Events
ECCMID 2022 Presentation Details Crestone presents at the 32nd European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) in Lisbon, Portugal. Oral Session: Discovery of CRS0393, a Potent MmpL3 Inhibitor as a Novel Antimycobacterial...
by Crestone, Inc. | Apr 28, 2022 | Events
2022 National C. Diff Advocacy Summit Presentation Details Crestone presents at the largest gathering of C. diff advocates and allies in industry, academia and policymaking in the country. Find out more about this event and the Peggy Lillis foundation by visiting...
by Crestone, Inc. | Nov 4, 2021 | Events
C. diff International Conference & Health EXPO Presentation Details Crestone, Inc. presents at the C. diff. International Conference & Health EXPO.
by Crestone, Inc. | Jun 8, 2021 | Press Releases
June 8, 2021 – Announcement: Crestone, Inc. joins the Antimicrobials Working Group to Combat Drug Resistant Infections June 8, 2021. The Antimicrobials Working Group (AWG) announced today the addition of Crestone, Inc. to its coalition of companies with the...
